Method of preparation of the suspension of xenolithic pork spleen for use in the treatment of patients with pathological changes in immune status


(57) Abstract:

The invention relates to medicine and can be applied to immune and immunomodulation. Method of preparation of the suspension of xenolithic includes perfusion transverse slices of pork spleen sterile saline solution, centrifugation, removal of the Packed fluid and the dilution of sediment saline solution in a ratio of 1:10. Technical result: suspension xenolithic pork spleen, cooked in this way, when introduced into the patient's body acts as humoral and cellular immunity of the person and reduces the frequency of adverse and allergic reactions in patients on the introduction of xenophobia. 3 Il.

The invention relates to medicine.

In medical practice the different ways of getting xenophobia pork spleen by perfusion of whole body sterile solutions for inclusion of xenophobia in the traditional scheme of treatment of patients with compromised immune status to immune and immunomodulation. A prototype of the selected method proposed by S. D. Nikonov: "Application of the perfusion solution xenoculture in the treatment of patients with extensive Novosibirsk, 1992.). When this methodology is taken at the slaughterhouse slaughterhouse pig spleen in sterile conditions is transported to a medical facility where the catheterization of the splenic artery minor artery and vein tied, then washed the blood and clots from the vascular bed of the spleen by injection with a syringe of saline solution with heparin in an artery of the spleen. As soon as the blood begins to flow through the splenic vein, the last fix and kanyoro. Then proceed to the perfusion of the spleen. For this system for drip infusion is attached to the bottle with saline solution, which is installed in a tripod at a height of 120 cm above the level of the tray with the spleen, and then connected to the blood catheter. During perfusion flowing from the splenic vein perfusion solution collected in sterile vials. For the removal of cells passengers use the techniques settling, or centrifugation. This supernatant under conditions of asepsis and antisepsis is pumped into a sterile container. For cooking xenophobia can be used and other solutions, for example, reopoliglyukin. Technical support and the way the sentence is ykov from staff when catheterization and kanalirovanii vessels.

The technique of obtaining xenophobia allows you to prepare a mixture of soluble biologically active substances of the spleen, however, cellular elements, represented mainly by lymphocytes which play a role in the implementation of immunocorrective and immunomodulating effect, thus artificially removed or destroyed, lyse.

There are other methods: Burdina, Century Manuilov B. M."the Role of factors secreted by the spleen, in the activation of phagocytes." Transplantation and artificial organs, M. M., 1986, S. 48-52. Slobod A. L., Bekchintaev I.e. "A modified technique using xenogenic spleen with purulent-septic diseases. Bulletin of the surgery. I. I. Grekova, 1991, No. 2, S. 96-100. Derived, A. "the Use of extracorporeal xenoplanets and perfusion solution of xenoculture in complex treatment of patients with peritonitis." M3 Grew. Federation. The research Institute of Transplantology and arts. the bodies of the candles. the honey. Sciences. M. 1993. C. 24. Nikonov, S. D. "the Effectiveness of perfusate xenoculture in the treatment of purulent-septic diseases in pulmonary surgery." The Novosibirsk. the honey. in-t, Kida. the honey. of Sciences, Novosibirsk. 1992. C. 22. Sitnikov C. A., Stagnina S. N., Tikhonov centuries, Deryabin, A., "Experimental oblecenie purulent-septic complications in surgery. "Nizhny Novgorod honey. journal 1991. N 2. C. 3-6.

The inventive method of preparation has the task of obtaining a suspension of living xenolithic porcine spleen in high concentration 15 105(ml) a solution of biologically active substances spleen by reducing the amount in the solution of tissue debris and cellular debris, which is achieved by centrifugation of xenophobia and save the bottom portions containing these cellular elements, with tissue debris and cellular debris (like a lighter) will be in the supernatant. Received a suspension of xenolithic when introducing it into the body of the patient will affect both humoral and cellular immunity of the person. Reduced the amount of tissue debris and cellular debris in the solution will reduce the number of adverse and allergic reactions of the patient to the introduction of suspended Xenocrates.

In Fig. 1 shows a system for otemanu crushed spleen (schematically shown assembled system to launder the spleen, showing the main components, the fluid flow in the system during operation;

in Fig.2 is a system for obtaining xenophobia ( schematically shown a system for receiving Xeno and perfusion of the spleen);

in Fig. 3 - remove the supernatant liquid from the vial containing the centrifuged xenophontos ( schematically indicated the correct location of the devices for removing the supernatant liquid from the vial xenophontos after centrifugation).

The proposed method is as follows.

The first step is to fence pork spleen, performed at the factory in the slaughterhouse to the lines. The fence is held by a special team under conditions of sterility. Extracted spleen in a sterile container (thermos) is transported to a medical facility, where it will be prepared suspension xenolithic porcine spleen. The transport duration should not exceed one and a half hours after casting. Preparation of spleen is carried out in a specially designed space (clean dressing, procedural, Department of detoxification, etc.,) in sterile conditions. Sterile tray spleen crushed scissors or a scalpel. The thickness of the pieces should not exceed 1 cm, weight - 2-3 g, the spleen is cut transversely to the longitudinal axis. Crushed spleen is placed in sterilized glass jars tsya sterile solution (for this you can use isotonic NaCl solution, latosol, disol), shake vigorously, the solution is poured.

This procedure is repeated twice to remove blood and tissue detritus. Then cooked the spleen is filled with a solution of the antibiotic with the aim of eliminating trapped in the container when cooking and the fence spleen microorganisms. You can use metronidazole (100 ml per 1 jar) or cephalosporins (average dose of 1 g per 1 Bank). The exposure time of the spleen with antibiotics from 4 to 24 hours, depending on what time you will need suspension xenolithic porcine spleen. At the time of exposure to antibiotic spleen is placed in the refrigerator storage temperature 0 - -4oC.

Suspension xenolithic pork spleen is prepared immediately before its introduction to the patient. This requires a roller pump 1, a slit-like nozzle 2, one dropper (preferably domestic production)3, the system for blood transfusion 4, 30-cm rubber tube 5 with an inner diameter of 0.6-0.8 cm, sterile solutions (physiological NaCl, 4 bottles of 400 ml) 6. The initial stage of preparation of the suspension of xenolithic pork spleen is getting xenopho, going system for hemosorption, where the capacity of the sorbent replaced the bottle with crushed spleen (see Fig. 1) and is laundering column of sterile saline. Pure saline when this system is connected to the blood collection and roller pump is forced through the column at a speed of 60 - 80 ml/min Volume of the leaching solution is on average 1200 ml. then to 400-ml bottle with sterile physiological saline, is connected to the system for blood transfusion ("fence"), connects the drip, which returns the liquid which has passed through a column of crushed spleen ("return"). Thus the roller pump will be "chasing" the saline solution in a closed loop (see Fig. 2). Xenophobic for the subsequent preparation of the suspension of xenolithic pork spleen is obtained by circulating the saline solution with a speed of 40 - 60 ml/min in a closed loop for 15-20 minutes At the end of this time the saline solution in the vial becomes light yellow color becomes slightly cloudy. The concentration of cells in it an average of 3.5 to 5.0 105in ml, the cell viability 70 - 79%. Cells that are in the solution of biologically active weselna presents lymphocytes - about 95% of all cells) is the so - called xenophobic.

The next stage bottle with xenophontos centrifuged in a centrifuge at a speed of 1200 revolutions per minute for 10 minutes. Then the vial is removed from a glass centrifuge, is opened and the supernatant is aspirated by a thin wall with a sterile glass pipette (8) attached to the vacuum-suction (see Fig. 3). On bottom of the vial should be about 3 milliliters of sedimentary fluid. Add 20-30 ml of sterile saline, the contents of the vial gently shaken, stirred. The obtained liquid volume presents dissolved biologically active substances spleen (cytokines are soluble factors of the immune cells, interleukins 1 and 2, interferon) and suspended in them xenolithic porcine spleen (mainly lymphocytes about 95% of all cells). The concentration of cells and their viability in the percentage of dead cells determined immediately after preparation of the suspension and is according to our data 15 105and 79% and 85% respectively. Obtained by this method of suspension xenolithic pork spleen with the introduction of it in the human body effect on humoral immunity is deystviy immunocompetent cells of the porcine and human organisms - cognate interaction) implementing fully its immunomodulating and immunostimulating effect, which allows its use in medicine.

Method of preparation of the suspension of xenolithic pork spleen for use in the treatment of patients with pathological changes in immune status in which perfusion of porcine spleen sterile saline solution, characterized in that prepared by perfusion of transverse slices of fresh pork spleen sterile solutions xenophobic centrifuged, the supernatant removed, the residue diluted with sterile saline solution in a ratio of 1 : 10.


Same patents:

The invention relates to medicine, in particular for cell therapy and can be used for the treatment of diseases caused by disorders of the immune system, for example, diabetes
The invention relates to ophthalmology

The invention relates to medicine, namely General medicine and dentistry

The invention relates to medicine, namely to methods for preparations from bone marrow, in particular negative regulators of hemopoiesis
The invention relates to medicine, in particular for surgical treatment of musculoskeletal system
The invention relates to medicine, namely the creation of an organ-specific homeopathic drugs for stimulation of myeloid and lymphoid blood sprouts
Solution: bone // 2055535
The invention relates to medicine, namely to traumatology and orthopedics, dental surgery, and can be used in the treatment of patients with lesions of bone

FIELD: medicine, surgery, transplantology.

SUBSTANCE: embryonic spleen should be sampled, washed in nutritive medium № 199 to be placed into fresh medium № 199 to obtain homogenate in teflon homogenizer followed by centrifuging; then one should isolate the upper, medium and inferior layers, suck off medium layer and the upper part of inferior layer; the cell mixture obtained should be diluted in nutritive medium № 199 to be then introduced by injections into mesentery of small intestine or rectus muscle of abdomen. The present innovation favors the activation of immune system in patients undergone splenectomic operation and in those in case of surgical immunodefficient state due to high functional and regenerating activity of transferred embryonic splenic cells.

EFFECT: higher efficiency of prophylaxis.

6 dwg, 2 tbl

FIELD: medicine.

SUBSTANCE: method involves using mononuclear autologic marrow fraction containing 6-9x104 mesenchyma cells per 1 ml or autologic mesenchyma trunk cells. The cells are separated from brain bioptate in the amount of 106 cells/kg of patient body mass. The preparations are intracoronarily introduced in fractions at a rate of 3-5 ml/min into the right coronary artery. The introduction is also carried out in intra-arterial mode in jets or in drops.

EFFECT: higher survival rate and life quality of cardiologic patients.

1 dwg

FIELD: medicine.

SUBSTANCE: method involves introducing autologic mesenchyma trunk cells as a single intravenous drop dose or in the amount of 1 mln cells per 1 kg of patient body weight.

EFFECT: provided stable clinical remission.

FIELD: medicine, surgery.

SUBSTANCE: method involves every day covering a wound with an agent comprising of pig spleen homogenate and oxygenated with perfluorane taken in the following amounts: 100 g of pig spleen homogenate and 10 ml of oxygenated perfluorane. Invention promotes to accelerating sanitation of suppurative wounds due to activation of topical immunity and activation of regenerating processes. Invention can be used in treatment of suppurative wounds.

EFFECT: improved treatment method of wounds.

2 ex

FIELD: medicine, oncourology.

SUBSTANCE: the present innovation deals with treating locally spread tumor diseases of urinary bladder due to applying either chemo- and/or radiation therapy. Moreover, one should intravenously once inject by drops autologous mesenchymal stem cells (AMSC) at the quantity of 1 mln cells/kg patient's body weight. Moreover, in case of chemotherapy AMSC should be injected during the period before the 20-th d after the last injection of chemopreparation, in case of radiation therapy - 12-15 d against the day of irradiation. In case of chemoradiation therapy AMSC should be injected after chemotherapy before the course of radiation therapy. This method enables to carry out chemoradiation therapy in patients with severe accompanying diseases that prevent such a therapy, and prevent the development of general toxic complications of chemoradiation therapy and medicinal and radiation-caused cystitis.

EFFECT: higher efficiency of therapy.

3 ex, 2 tbl

FIELD: medicine; medical engineering.

SUBSTANCE: biotransplant has genetically unmodified mesenchyma stem cell culture as active component obtained from fetal donor autologous material. The tissue is subjected to disaggregation and the produced cell suspension is resuspended and cultivated on growth medium containing transferrin, insulin, fibroblast growth factor and heparin to accumulate mature stroma in cell culture. Method involves intravenously dropping mesenchyma stem cell culture in the amount of 50 to 500 mln in 50-100 ml of physiologic saline.

EFFECT: accelerated recovery of bone tissue; positive biochemical factors dynamics; improved patient locomotor activity.

6 cl

FIELD: medicine; medical engineering.

SUBSTANCE: biotransplant has genetically unmodified mesenchyma stem cell culture as active component obtained from fetal donor autologous material and genetically unmodified fetal myoblast culture. Method involves intravenously dropping mesenchyma stem cells in the amount of 50 to 500 mln in 50-100 ml of physiologic saline. The fetal myoblast culture is intramuscularly introduced at a dose of 100 mln of cells per 10 kg.

EFFECT: enhanced effectiveness in repairing incretory function of pancreas and reducing resistance to insulin; reduced risk of nephropathy and other complications.

9 cl

FIELD: medicine, cardiology.

SUBSTANCE: one should introduce the suspension of autologous mononuclear medullary cells without preliminary cultivation in to the mouth of coronary artery nourishing infarction area. Cell suspension should be introduced at the quantity of 100-150 mln. cells immediately after stenting coronary artery due to technique of passive passage. The procedure should be performed on the 14th - 21st d against the onset of the disease mentioned. The method provides efficient counterbalance of cardiomyocytes due to applying valuable stem cells at excluding complications induced by arterial occlusion.

EFFECT: higher efficiency of therapy.

1 ex, 1 tbl

FIELD: medicine, in particular hematology.

SUBSTANCE: CBA/CaLac intact mouse spleen is homogenized in medium containing 95 % of RPMI-1640 and 5 % of ethyl silicate; filtered through nylon grid; washed by centrifugation with RPMI-1640. at 1500 rpm for 10-15 min; final concentration of living splenocites is adjusted to 2x106 colony/ml using media containing 10 % of ethyl silicate, 1 % of L-glutamine; 0.2 % of gentamycine, 0.05 % of mercaptoethanol, 89 % of RPMI-1640; obtained product is cultivated at 37°C for 6 days, centrifuged and supernatant containing target product is separated followed by storage at -20°C. Before filtering 1 ml of distilled water is added in sterile spleen homogenate and after 25 sec 10 ml of RPMI-1640 medium is added. Target product is stored for 1 month or less.

EFFECT: method of improved accuracy and validity.

1 tbl

FIELD: medicine, in particular uses of viruses for cell elimination.

SUBSTANCE: invention relates to uses of viruses capable of reducing undesired cells in ex vivo mixtures of normal marrow or peripheral blood cells and tumor cells, such as leucosis or lymphoma cells due to interaction of abovementioned mixture with vesicular stomatitis virus. Invention also relates to method for malignant tumor treatment in mammalian. Claimed method includes sampling of mammalian marrow or peripheral blood cells; interaction of said cells ex vivo with vesicular stomatitis virus; mieloablative therapy; and transplantation of purified hematopoietic cells into mammalian. In another embodiment invention relates to method for malignant tumor treatment in mammalian having transplant of marrow or peripheral blood stem cells. Said method includes interaction ex vivo of collected transplant cell with vesicular stomatitis virus and administration of these purified cells in mammalian. Method of present invention makes it possible to reduce risk of malignant tumor backset in mammalian with transplanted hematopoietic cells.

EFFECT: new agent for elimination of marrow or peripheral blood tumor cells.

12 cl, 4 ex, 3 tbl